PR

Patrick Joseph Roberts

GT G1 Therapeutics: 18 patents #3 of 31Top 10%
GT Gi Therapeutics: 3 patents #3 of 12Top 25%
UH University Of North Carolina At Chapel Hill: 2 patents #408 of 1,688Top 25%
PA Pharmacosmos Holding A/S: 1 patents #8 of 20Top 40%
Harvard University: 1 patents #1,740 of 3,600Top 50%
BH Brigham and Women's Hospital: 1 patents #847 of 1,764Top 50%
📍 Durham, NC: #179 of 4,103 inventorsTop 5%
🗺 North Carolina: #1,772 of 45,564 inventorsTop 4%
Overall (All Time): #168,124 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
12285431 Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors Jay Copeland Strum, John Emerson Bisi, Jessica A. Sorrentino 2025-04-29
11717523 Transient protection of normal cells during chemotherapy Jay Copeland Strum, John Emerson Bisi, Francis Xavier Tavares 2023-08-08
11654148 HSPC-sparing treatments for RB-positive abnormal cellular proliferation Jay Copeland Strum, John Emerson Bisi, Francis Xavier Tavares 2023-05-23
11529352 Preservation of immune response during chemotherapy regimens Jessica A. Sorrentino, Anne Lai, Jay Copeland Strum 2022-12-20
11446295 Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat Rb-positive tumors Jay Copeland Strum, John Emerson Bisi, Jessica A. Sorrentino, Hannah S. White 2022-09-20
11090306 Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors Jay Copeland Strum, John Emerson Bisi, Jessica A. Sorrentino 2021-08-17
11040042 Transient protection of normal cells during chemotherapy Jay Copeland Strum, John Emerson Bisi, Francis Xavier Tavares 2021-06-22
10966984 Transient protection of normal cells during chemotherapy Jay Copeland Strum, John Emerson Bisi, Francis Xavier Tavares 2021-04-06
10925878 HSPC-sparing treatments for RB-positive abnormal cellular proliferation Jay Copeland Strum, John Emerson Bisi, Francis Xavier Tavares 2021-02-23
10709711 Highly active anti-neoplastic and anti-proliferative agents Jay Copeland Strum, John Emerson Bisi, Francis Xavier Tavares 2020-07-14
10660896 Transient protection of normal cells during chemotherapy Jay Copeland Strum, John Emerson Bisi, Francis Xavier Tavares 2020-05-26
10434104 HSPC-sparing treatments for Rb-positive abnormal cellular proliferation Jay Copeland Strum, John Emerson Bisi, Francis Xavier Tavares 2019-10-08
10413547 Treatment of Rb-negative tumors using topoisomerase with cyclin dependent kinase 4/6 inhibitors Jay Copeland Strum, John Emerson Bisi, Jessica A. Sorrentino 2019-09-17
10376519 Tricyclic lactams for use in HSPC-sparing treatments for Rb-positive abnormal cellular proliferation Jay Copeland Strum, John Emerson Bisi, Ricky D. Gaston, Robert C. Gadwood 2019-08-13
10231969 Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat RB-positive tumors Jay Copeland Strum, John Emerson Bisi, Jessica A. Sorrentino, Hannah S. White 2019-03-19
10085992 Transient protection of normal cells during chemotherapy Jay Copeland Strum, John Emerson Bisi, Francis Xavier Tavares 2018-10-02
10076523 HSPC-sparing treatments for RB-positive abnormal cellular proliferation Jay Copeland Strum, John Emerson Bisi, Francis Xavier Tavares 2018-09-18
9931345 Transient protection of normal cells during chemotherapy Jay Copeland Strum, John Emerson Bisi, Francis Xavier Tavares 2018-04-03
9808461 Protection of renal tissues from ischemia through inhibition of the proliferative kinases CDK4 and CDK6 Derek Dirocco, Norman E. Sharpless, Jay Copeland Strum, John Emerson Bisi, Benjamin D. Humphreys +1 more 2017-11-07
9717735 Tricyclic lactams for use in HSPC-sparing treatments for RB-positive abnormal cellular proliferation Jay Copeland Strum, John Emerson Bisi, Ricky D. Gaston, Robert C. Gadwood 2017-08-01
9616062 Cyclin dependent kinase inhibitors and methods of use Norman E. Sharpless, Kwok-Kin Wong, Soren Johnson 2017-04-11
9527857 HSPC-sparing treatments for RB-positive abnormal cellular proliferation Jay Copeland Strum, John Emerson Bisi, Francis Xavier Tavares 2016-12-27
9487530 Transient protection of normal cells during chemotherapy Jay Copeland Strum, John Emerson Bisi, Francis Xavier Tavares 2016-11-08
9464092 Transient protection of normal cells during chemotherapy Jay Copeland Strum, John Emerson Bisi, Francis Xavier Tavares 2016-10-11